Efficacy and Safety Study of SHR117887 in Combination With Metformin in Patients With Type 2 Diabetes

NCT01984489 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Placebo
DRUG: SHR117887

Sponsor

Jiangsu HengRui Medicine Co., Ltd.